Towards targeted therapy for infant acute lymphoblastic leukaemia

British Journal of Haematology

Volumn 132, Issue 5, 2006, Pages 539-551

  Stam, Ronald W ^a   Den Boer, Monique L ^a   Pieters, Rob ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Acute lymphoblastic leukaemia; Drug resistance; Infant; Mixed lineage leukaemia translocation; Targeted therapy

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ANTHRACYCLINE; ARGINASE; AZACITIDINE; CEP 701; CLADRIBINE; CLOFARABINE; CYTARABINE; DEXAMETHASONE; DNA TOPOISOMERASE INHIBITOR; EPIPODOPHYLLOTOXIN DERIVATIVE; ETODOLAC; ETOPOSIDE; FLT3 LIGAND; GENISTEIN; GLUCOCORTICOID; HERMES ANTIGEN; MIXED LINEAGE LEUKEMIA PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY A3D8; MONOCLONAL ANTIBODY HL44A; MULTIDRUG RESISTANCE PROTEIN; N BENZOYLSTAUROSPORINE; PREDNISONE; QUERCETIN; ROSCOVITINE; SDX 101; SEMAXANIB; TROXACITABINE; UNCLASSIFIED DRUG; ZEBULARINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALCOHOLISM; BLOOD PLACENTA BARRIER; CANCER RESISTANCE; CANCER RISK; CHERNOBYL ACCIDENT; CHILDHOOD LEUKEMIA; CONCENTRATION RESPONSE; DRUG TARGETING; FOOD INTAKE; GENE EXPRESSION; GENE REARRANGEMENT; HUMAN; LEUKEMIA REMISSION; LEUKEMOGENESIS; MATERNAL BEHAVIOR; MOLECULAR DYNAMICS; PATERNAL BEHAVIOR; PRENATAL PERIOD; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SIDE EFFECT; SMOKING; TREATMENT OUTCOME;

AGE OF ONSET; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FORECASTING; GENE REARRANGEMENT; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MUTATION; MYELOID-LYMPHOID LEUKEMIA PROTEIN; PROGNOSIS; REMISSION INDUCTION; TRANSLOCATION, GENETIC;

EID: 33644886602     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05909.x     Document Type: Review

References (138)

1. Andersen M.K. Christiansen D.H. Jensen B.A. Ernst P. Hauge G. Pedersen-Bjergaard J. 2001 Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992 British Journal of Haematology 114 539 543
2. Armstrong S.A. Staunton J.E. Silverman L.B. Pieters R. den Boer M.L. Minden M.D. Sallan S.E. Lander E.S. Golub T.R. Korsmeyer S.J. 2002 MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia Nature Genetics 30 41 47
3. Armstrong S.A. Golub T.R. Korsmeyer S.J. 2003a MLL-rearranged leukemias: insights from gene expression profiling Seminars in Hematology 40 268 273
4. Armstrong S.A. Kung A.L. Mabon M.E. Silverman L.B. Stam R.W. Den Boer M.L. Pieters R. Kersey J.H. Sallan S.E. Fletcher J.A. Golub T.R. Griffin J.D. Korsmeyer S.J. 2003b Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification Cancer Cell 3 173 183
5. Basso G. Putti M.C. Cantu-Rajnoldi A. Saitta M. Santostasi T. Santoro N. Lippi A. Comelli A. Felici L. Favre C. RussoMancuso R. Guglielmi C. Paolucci P. Biondi A. Rondelli R. Pession A. 1992 The immunophenotype in infant acute lymphoblastic leukaemia: correlation with clinical outcome. An Italian multicentre study (AIEOP) British Journal of Haematology 81 184 191
6. Battle T.E. Arbiser J. Frank D.A. 2005 The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells Blood 106 690 697
7. Biondi A. Cimino G. Pieters R. Pui C.H. 2000 Biological and therapeutic aspects of infant leukemia Blood 96 24 33
8. Bouffard D.Y. Jolivet J. Leblond L. Hamelin B. Ouellet F. Barbeau S. Richard A. Gourdeau H. 2003 Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells Cancer Chemotherapy and Pharmacology 52 497 506
9. Brown P. Levis M. Shurtleff S. Campana D. Downing J. Small D. 2005 FLT3 inhibition selectively kills childhood acute lymphoblastic leukemia cells with high levels of FLT3 expression Blood 105 812 820
10. Campbell M. Cabrera M.E. Legues M.E. Ridge S. Greaves M. 1996 Discordant clinical presentation and outcome in infant twins sharing a common clonal leukaemia British Journal of Haematology 93 166 169
11. Charrad R.S. Gadhoum Z. Qi J. Glachant A. Allouche M. Jasmin C. Chomienne C. Smadja-Joffe F. 2002 Effects of anti-CD44 monoclonal antibodies on differentiation and apoptosis of human myeloid leukemia cell lines Blood 99 290 299
12. Cheng J.C. Matsen C.B. Gonzales F.A. Ye W. Greer S. Marquez V.E. Jones P.A. Selker E.U. 2003 Inhibition of DNA methylation and reactivation of silenced genes by zebularine Journal of the National Cancer Institute 95 399 409
13. Chessells J.M. Eden O.B. Bailey C.C. Lilleyman J.S. Richards S.M. 1994 Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia Leukemia 8 1275 1279
14. Chessells J.M. Harrison C.J. Watson S.L. Vora A.J. Richards S.M. 2002 Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987-1999 British Journal of Haematology 117 306 314
15. Chow K.U. Boehrer S. Napieralski S. Nowak D. Knau A. Hoelzer D. Mitrou P.S. Weidmann E. 2003 In AML cell lines Ara-C combined with purine analogues is able to exert synergistic as well as antagonistic effects on proliferation, apoptosis and disruption of mitochondrial membrane potential Leukemia and Lymphoma 44 165 173
16. Cimino G. Rapanotti M.C. Rivolta A. Lo Coco F. D'Arcangelo E. Rondelli R. Basso G. Barisone E. Rosanda C. Santostasi T. Canaani E. Masera G. Mandelli F. Biondi A. 1995 Prognostic relevance of ALL-1 gene rearrangement in infant acute leukemias Leukemia 9 391 395
17. Cimino G. Rapanotti M.C. Biondi A. Elia L. Lo Coco F. Price C. Rossi V. Rivolta A. Canaani E. Croce C.M. Mandelli F. Greaves M. 1997 Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias Cancer Research 57 2879 2883
18. Cox C.V. Evely R.S. Oakhill A. Pamphilon D.H. Goulden N.J. Blair A. 2004 Characterization of acute lymphoblastic leukemia progenitor cells Blood 104 2919 2925
19. Cumano A. Paige C.J. Iscove N.N. Brady G. 1992 Bipotential precursors of B cells and macrophages in murine fetal liver Nature 356 612 615
20. Daser A. Rabbitts T.H. 2004 Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis Genes and Development 18 965 974
21. Den Boer M.L. Harms D.O. Pieters R. Kazemier K.M. Gobel U. Korholz D. Graubner U. Haas R.J. Jorch N. Spaar H.J. Kaspers G.J. Kamps W.A. Van der Does-Van den Berg A. Van Wering E.R. Veerman A.J. Janka-Schaub G.E. 2003 Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia Journal of Clinical Oncology 21 3262 3268
22. Dordelmann M. Reiter A. Borkhardt A. Ludwig W.D. Gotz N. Viehmann S. Gadner H. Riehm H. Schrappe M. 1999 Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia Blood 94 1209 1217
23. Faderl S. Gandhi V. Keating M.J. Jeha S. Plunkett W. Kantarjian H.M. 2005 The role of clofarabine in hematologic and solid malignancies-Development of a next-generation nucleoside analog Cancer 103 1985 1995
24. Fais F. Tenca C. Cimino G. Coletti V. Zanardi S. Bagnara D. Saverino D. Zarcone D. De Rossi G. Ciccone E. Grossi C.E. 2005 CD1d expression on B-precursor acute lymphoblastic leukemia subsets with poor prognosis Leukemia 19 551 556
25. Fasching K. Panzer S. Haas O.A. Borkhardt A. Marschalek R. Griesinger F. Panzer-Grumayer E.R. 2001 Presence of N regions in the clonotypic DJ rearrangements of the immunoglobulin heavy-chain genes indicates an exquisitely short latency in t(4;11)-positive infant acute lymphoblastic leukemia Blood 98 2272 2274
26. Ferster A. Bertrand Y. Benoit Y. Boilletot A. Behar C. Margueritte G. Thyss A. Robert A. Mazingue F. Souillet G. Philippe N. Solbu G. Suciu S. Otten J. 1994 Improved survival for acute lymphoblastic leukaemia in infancy: the experience of EORTC-Childhood Leukaemia Cooperative Group British Journal of Haematology 86 284 290
27. Fine B.M. Stanulla M. Schrappe M. Ho M. Viehmann S. Harbott J. Boxer L.M. 2004 Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia Blood 103 1043 1049
28. Ford A.M. Ridge S.A. Cabrera M.E. Mahmoud H. Steel C.M. Chan L.C. Greaves M. 1993 In utero rearrangements in the trithorax-related oncogene in infant leukaemias Nature 363 358 360
29. Frankel L.S. Ochs J. Shuster J.J. Dubowy R. Bowman W.P. Hockenberry-Eaton M. Borowitz M. Carroll A.J. Steuber C.P. Pullen D.J. 1997 Therapeutic trial for infant acute lymphoblastic leukemia: the Pediatric Oncology Group experience (POG 8493) Journal of Pediatric Hematology/oncology 19 35 42
30. Frater J.L. Batanian J.R. O'Connor D.M. Grosso L.E. 2004 Lymphoblastic leukemia with mature B-cell phenotype in infancy Journal of Pediatric Hematology/oncology 26 672 677
31. Gadhoum Z. Delaunay J. Maquarre E. Durand L. Lancereaux V. Qi J. Robert-Lezenes J. Chomienne C. Smadja-Joffe F. 2004 The effect of anti-CD44 monoclonal antibodies on differentiation and proliferation of human acute myeloid leukemia cells Leukemia and Lymphoma 45 1501 1510
32. Gale K.B. Ford A.M. Repp R. Borkhardt A. Keller C. Eden O.B. Greaves M.F. 1997 Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots Proceedings of the National Academy of Sciences of the United States of America 94 13950 13954
33. Gati W.P. Paterson A.R. Larratt L.M. Turner A.R. Belch A.R. 1997 Sensitivity of acute leukemia cells to cytarabine is a correlate of cellular es nucleoside transporter site content measured by flow cytometry with SAENTA-fluorescein Blood 90 346 353
34. Ghaffari S. Dougherty G.J. Eaves A.C. Eaves C.J. 1996 Altered patterns of CD44 epitope expression in human chronic and acute myeloid leukemia Leukemia 10 1773 1781
35. Giles F.J. Garcia-Manero G. Cortes J.E. Baker S.D. Miller C.B. O'Brien S.M. Thomas D.A. Andreeff M. Bivins C. Jolivet J. Kantarjian H.M. 2002 Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with refractory leukemia Journal of Clinical Oncology 20 656 664
36. Gill Super H.J. Rothberg P.G. Kobayashi H. Freeman A.I. Diaz M.O. Rowley J.D. 1994 Clonal, nonconstitutional rearrangements of the MLL gene in infant twins with acute lymphoblastic leukemia: in utero chromosome rearrangement of 11q23 Blood 83 641 644
37. Gilliland D.G. Griffin J.D. 2002 The roles of FLT3 in hematopoiesis and leukemia Blood 100 1532 1542
38. Greaves M.F. 1993 Stem cell origins of leukaemia and curability British Journal of Cancer 67 413 423
39. Greaves M.F. 1996 Infant leukaemia biology, aetiology and treatment Leukemia 10 372 377
40. Gu Y. Nakamura T. Alder H. Prasad R. Canaani O. Cimino G. Croce C.M. Canaani E. 1992 The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene Cell 71 701 708
41. Gutierrez M.I. Siraj A.K. Bhargava M. Ozbek U. Banavali S. Chaudhary M.A. El Solh H. Bhatia K. 2003 Concurrent methylation of multiple genes in childhood ALL: correlation with phenotype and molecular subgroup Leukemia 17 1845 1850
42. Heerema N.A. Sather H.N. Ge J. Arthur D.C. Hilden J.M. Trigg M.E. Reaman G.H. 1999 Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosis of infants with t(4;11) - a report of the Children's Cancer Group Leukemia 13 679 686
43. Hess J.L. 2004 Mechanisms of transformation by MLL Critical Reviews in Eukaryotic Gene Expression 14 235 254
44. Hilden J.M. Frestedt J.L. Moore R.O. Heerema N.A. Arthur D.C. Reaman G.H. Kersey J.H. 1995 Molecular analysis of infant acute lymphoblastic leukemia: MLL gene rearrangement and reverse transcriptase-polymerase chain reaction for t(4; 11)(q21; q23) Blood 86 3876 3882
45. Holleman A. Cheok M.H. den Boer M.L. Yang W. Veerman A.J. Kazemier K.M. Pei D. Cheng C. Pui C.H. Relling M.V. Janka-Schaub G.E. Pieters R. Evans W.E. 2004 Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment New England Journal of Medicine 351 533 542
46. Holowiecki J. Grosicki S. Robak T. Kyrcz-Krzemien S. Giebel S. Hellmann A. Skotnicki A. Jedrzejczak W.W. Konopka L. Kuliczkowski K. Zdziarska B. Dmoszynska A. Marianska B. Pluta A. Zawilska K. Komarnicki M. Kloczko J. Sulek K. Haus O. Stella-Holowiecka B. Baran W. Jakubas B. Paluszewska M. Wierzbowska A. Kielbinski M. Jagoda K. 2004 Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study Leukemia 18 989 997
47. - cells Cancer Research 65 1442 1449
48. Hubeek I. Peters G.J. Broekhuizen A.J. Kaspers G.J. 2004 Modulation of cytarabine induced cytotoxicity using novel deoxynucleoside analogs in the HL60 cell line Nucleosides Nucleotides Nucleic Acids 23 1513 1516
49. Huret J.L. Dessen P. Bernheim A. 2001 An atlas of chromosomes in hematological malignancies. Example: 11q23 and MLL partners Leukemia 15 987 989
50. Iida S. Seto M. Yamamoto K. Komatsu H. Tojo A. Asano S. Kamada N. Ariyoshi Y. Takahashi T. Ueda R. 1993 MLLT3 gene on 9p22 involved in t(9;11) leukemia encodes a serine/proline rich protein homologous to MLLT1 on 19p13 Oncogene 8 3085 3092
51. Ishii E. Okamura J. Tsuchida M. Kobayashi M. Akiyama Y. Nakahata T. Kojima S. Hanada R. Horibe K. Sato T. Komada Y. Kimura K. Sakaguchi C. Hosoya R. Oda M. Tsunematsu Y. Kawa K. Konishi S. Tsukimoto I. Matsuyama K. Ueda K. 1991 Infant leukemia in Japan: clinical and biological analysis of 48 cases Medical and Pediatric Oncology 19 28 32
52. Isoyama K. Eguchi M. Hibi S. Kinukawa N. Ohkawa H. Kawasaki H. Kosaka Y. Oda T. Oda M. Okamura T. Nishimura S. Hayashi Y. Mori T. Imaizumi M. Mizutani S. Tsukimoto I. Kamada N. Ishii E. 2002 Risk-directed treatment of infant acute lymphoblastic leukaemia based on early assessment of MLL gene status: results of the Japan Infant Leukaemia Study (MLL96) British Journal of Haematology 118 999 1010
53. Jeha S. Gandhi V. Chan K.W. McDonald L. Ramirez I. Madden R. Rytting M. Brandt M. Keating M. Plunkett W. Kantarjian H. 2004 Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia Blood 103 784 789
54. Juliusson G. Hoglund M. Karlsson K. Lofgren C. Mollgard L. Paul C. Tidefelt U. Bjorkholm M. 2003 Increased remissions from one course for intermediate-dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine. A randomized population-based phase II study British Journal of Haematology 123 810 818
55. Kaspers G.J. Kardos G. Pieters R. Van Zantwijk C.H. Klumper E. Hahlen K. de Waal F.C. van Wering E.R. Veerman A.J. 1994 Different cellular drug resistance profiles in childhood lymphoblastic and non-lymphoblastic leukemia: a preliminary report Leukemia 8 1224 1229
56. Kaspers G.J. Pieters R. Van Zantwijk C.H. Van Wering E.R. Van Der Does-Van Den Berg A. Veerman A.J. 1998 Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs Blood 92 259 266
57. Kawagoe H. Kawagoe R. Sano K. 2001 Targeted down-regulation of MLL-AF9 with antisense oligodeoxyribonucleotide reduces the expression of the HOXA7 and -A10 genes and induces apoptosis in a human leukemia cell line, THP-1 Leukemia 15 1743 1749
58. Kaye S.A. Robison L.L. Smithson W.A. Gunderson P. King F.L. Neglia J.P. 1991 Maternal reproductive history and birth characteristics in childhood acute lymphoblastic leukemia Cancer 68 1351 1355
59. Kosaka Y. Koh K. Kinukawa N. Wakazono Y. Isoyama K. Oda T. Hayashi Y. Ohta S. Moritake H. Oda M. Nagatoshi Y. Kigasawa H. Ishida Y. Ohara A. Hanada R. Sako M. Sato T. Mizutani S. Horibe K. Ishii E. 2004 Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantation Blood 104 3527 3534
60. Krawczuk-Rybak M. Zak J. Jaworowska B. 2003 A lineage switch from AML to ALL with persistent translocation t(4;11) in congenital leukemia Medical and Pediatric Oncology 41 95 96
61. Kristensen J. Nygren P. Liliemark J. Fridborg H. Killander A. Simonsson B. Oberg G. Larsson R. 1994 Interactions between cladribine (2- chlorodeoxyadenosine) and standard antileukemic drugs in primary cultures of human tumor cells from patients with acute myelocytic leukemia Leukemia 8 1712 1717
62. Lanciotti M. Dufour C. Corral L. Di Michele P. Pigullo S. De Rossi G. Basso G. Leszl A. Luciani M. Lo Nigro L. Micalizzi C. Valsecchi M.G. Biondi A. Haupt R. 2005 Genetic polymorphism of NAD(P)H:quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangements Leukemia 19 214 216
63. Lauer S.J. Camitta B.M. Leventhal B.G. Mahoney Jr. D. Shuster J.J. Kiefer G. Pullen J. Steuber C.P. Carroll A.J. Kamen B. 1998 Intensive alternating drug pairs after remission induction for treatment of infants with acute lymphoblastic leukemia: a Pediatric Oncology Group Pilot Study Journal of Pediatric Hematology/Oncology 20 229 233
64. Levis M. Allebach J. Tse K.F. Zheng R. Baldwin B.R. Smith B.D. Jones-Bolin S. Ruggeri B. Dionne C. Small D. 2002 A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo Blood 99 3885 3891
65. Levis M. Pham R. Smith B.D. Small D. 2004 In vitro studies of a FLT3 inhibitor combined with chemotherapy: sequence of administration is important to achieve synergistic cytotoxic effects Blood 104 1145 1150
66. Levis M. Murphy K.M. Pham R. Kim K.T. Stine A. Li L. McNiece I. Smith B.D. Small D. 2005 Internal tandem duplications of the FLT3 gene are present in leukemia stem cells Blood 106 673 680
67. Liebisch P. Eppinger S. Schopflin C. Stehle G. Munzert G. Dohner H. Schmid M. 2005 CD44v6, a target for novel antibody treatment approaches, is frequently expressed in multiple myeloma and associated with deletion of chromosome arm 13q Haematologica 90 489 493
68. Lovett B.D. Lo Nigro L. Rappaport E.F. Blair I.A. Osheroff N. Zheng N. Megonigal M.D. Williams W.R. Nowell P.C. Felix C.A. 2001 Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation Proceedings of the National Academy of Sciences of the United States of America 98 9802 9807
69. Ludwig W.D. Rieder H. Bartram C.R. Heinze B. Schwartz S. Gassmann W. Loffler H. Hossfeld D. Heil G. Handt S. Heyll A. Diedrich H. Fischer K. Weiss A. Volkers B. Aydemir U. Fonatsch C. Gokbuget N. Thiel E. Hoelzer D. 1998 Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89 Blood 92 1898 1909
70. Mackarehtschian K. Hardin J.D. Moore K.A. Boast S. Goff S.P. Lemischka I.R. 1995 Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors Immunity 3 147 161
71. Mahmoud H.H. Ridge S.A. Behm F.G. Pui C.H. Ford A.M. Raimondi S.C. Greaves M.F. 1995 Intrauterine monoclonal origin of neonatal concordant acute lymphoblastic leukemia in monozygotic twins Medical and Pediatric Oncology 24 77 81
72. Metodiewa D. Jaiswal A.K. Cenas N. Dickancaite E. Segura-Aguilar J. 1999 Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product Free Radical Biology and Medicine 26 107 116
73. Meyer C. Schneider B. Reichel M. Angermueller S. Strehl S. Schnittger S. Schoch C. Jansen M.W. van Dongen J.J. Pieters R. Haas O.A. Dingermann T. Klingebiel T. Marschalek R. 2005 Diagnostic tool for the identification of MLL rearrangements including unknown partner genes Proceedings of the National Academy of Sciences of the United States of America 102 449 454
74. Miller H.K. Salser J.S. Balis M.E. 1969 Amino acid levels following L-asparagine amidohydrolase (EC.3.5.1.1) therapy Cancer Research 29 183 187
75. Montecino-Rodriguez E. Leathers H. Dorshkind K. 2001 Bipotential B-macrophage progenitors are present in adult bone marrow Nature Immunology 2 83 88
76. Moysich K.B. Menezes R.J. Michalek A.M. 2002 Chernobyl-related ionising radiation exposure and cancer risk: an epidemiological review Lancet Oncol 3 269 279
77. Nakao M. Yokota S. Iwai T. Kaneko H. Horiike S. Kashima K. Sonoda Y. Fujimoto T. Misawa S. 1996 Internal tandem duplication of the flt3 gene found in acute myeloid leukemia Leukemia 10 1911 1918
78. O'Farrell A.M. Yuen H.A. Smolich B. Hannah A.L. Louie S.G. Hong W. Stopeck A.T. Silverman L.R. Lancet J.E. Karp J.E. Albitar M. Cherrington J.M. Giles F.J. 2004 Effects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemia Leukemia Research 28 679 689
79. Ohnuma T. Holland J.F. Freeman A. Sinks L.F. 1970 Biochemical and pharmacological studies with asparaginase in man Cancer Research 30 2297 2305
80. Opferman J.T. Letai A. Beard C. Sorcinelli M.D. Ong C.C. Korsmeyer S.J. 2003 Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1 Nature 426 671 676
81. Opferman J.T. Iwasaki H. Ong C.C. Suh H. Mizuno S. Akashi K. Korsmeyer S.J. 2005 Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells Science 307 1101 1104
82. Pieters R. 2003 Biology and treatment of infant leukemias In: Current Clinical Oncology: Treatment of Acute Leukemias: New Directions for Clinical Research ed. by Pui C.-H. pp 61 73 Humana Press Inc. Totowa, NJ
83. Pieters R. den Boer M.L. Durian M. Janka G. Schmiegelow K. Kaspers G.J. van Wering E.R. Veerman A.J. 1998 Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia-implications for treatment of infants Leukemia 12 1344 1348
84. Pui C.H. Behm F.G. Downing J.R. Hancock M.L. Shurtleff S.A. Ribeiro R.C. Head D.R. Mahmoud H.H. Sandlund J.T. Furman W.L. Roberts W.M. Crist W.M. Raimondi S.C. 1994 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia Journal of Clinical Oncology 12 909 915
85. Pui C.H. Kane J.R. Crist W.M. 1995a Biology and treatment of infant leukemias Leukemia 9 762 769
86. Pui C.H. Relling M.V. Rivera G.K. Hancock M.L. Raimondi S.C. Heslop H.E. Santana V.M. Ribeiro R.C. Sandlund J.T. Mahmoud H.H. Evans W.E. Crist W.M. Krance R.A. 1995b Epipodophyllotoxin-related acute myeloid leukemia: a study of 35 cases Leukemia 9 1990 1996
87. Pui C.H. Ribeiro R.C. Campana D. Raimondi S.C. Hancock M.L. Behm F.G. Sandlund J.T. Rivera G.K. Evans W.E. Crist W.M. Krance R. 1996 Prognostic factors in the acute lymphoid and myeloid leukemias of infants Leukemia 10 952 956
88. Pui C.H. Gaynon P.S. Boyett J.M. Chessells J.M. Baruchel A. Kamps W. Silverman L.B. Biondi A. Harms D.O. Vilmer E. Schrappe M. Camitta B. 2002 Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region Lancet 359 1909 1915
89. Pui C.H. Relling M.V. Downing J.R. 2004 Acute lymphoblastic leukemia New England Journal of Medicine 350 1535 1548
90. Puthier D. Derenne S. Barille S. Moreau P. Harousseau J.L. Bataille R. Amiot M. 1999 Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells British Journal of Haematology 107 392 395
91. Raje N. Kumar S. Hideshima T. Roccaro A. Ishitsuka K. Yasui H. Shiraishi N. Chauhan D. Munshi N.C. Green S.R. Anderson K.C. 2005 Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in multiple myeloma Blood 106 1042 1047
92. Ramakers-van Woerden N.L. Beverloo H.B. Veerman A.J. Camitta B.M. Loonen A.H. van Wering E.R. Slater R.M. Harbott J. den Boer M.L. Ludwig W.D. Haas O.A. Janka-Schaub G.E. Pieters R. 2004 In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype Leukemia 18 521 529
93. Reaman G.H. Sposto R. Sensel M.G. Lange B.J. Feusner J.H. Heerema N.A. Leonard M. Holmes E.J. Sather H.N. Pendergrass T.W. Johnstone H.S. O'Brien R.T. Steinherz P.G. Zeltzer P.M. Gaynon P.S. Trigg M.E. Uckun F.M. 1999 Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group Journal of Clinical Oncology 17 445 455
94. Ridge S.A. Cabrera M.E. Ford A.M. Tapia S. Risueno C. Labra S. Barriga F. Greaves M.F. 1995 Rapid intraclonal switch of lineage dominance in congenital leukaemia with a MLL gene rearrangement Leukemia 9 2023 2026
95. Riehm H. Reiter A. Schrappe M. Berthold F. Dopfer R. Gerein V. Ludwig R. Ritter J. Stollmann B. Henze G. 1987 [Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)] Klinische Padiatrie 199 151 160
96. Robison L.L. Codd M. Gunderson P. Neglia J.P. Smithson W.A. King F.L. 1987 Birth weight as a risk factor for childhood acute lymphoblastic leukemia Pediatric Hematology and Oncology 4 63 72
97. Ross J.A. 1998 Maternal diet and infant leukemia: a role for DNA topoisomerase II inhibitors International Journal of Cancer. Supplement 11 26 28
98. Ross J.A. Potter J.D. Robison L.L. 1994 Infant leukemia, topoisomerase II inhibitors, and the MLL gene Journal of the National Cancer Institute 86 1678 1680
99. Ross J.A. Potter J.D. Shu X.O. Reaman G.H. Lampkin B. Robison L.L. 1997 Evaluating the relationships among maternal reproductive history, birth characteristics, and infant leukemia: a report from the Children's Cancer Group Annals of Epidemiology 7 172 179
100. Ross M.E. Zhou X. Song G. Shurtleff S.A. Girtman K. Williams W.K. Liu H.C. Mahfouz R. Raimondi S.C. Lenny N. Patel A. Downing J.R. 2003 Classification of pediatric acute lymphoblastic leukemia by gene expression profiling Blood 102 2951 2959
101. Rubnitz J.E. Link M.P. Shuster J.J. Carroll A.J. Hakami N. Frankel L.S. Pullen D.J. Cleary M.L. 1994 Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: a Pediatric Oncology Group study Blood 84 570 573
102. Saxena A. Viswanathan S. Moshynska O. Tandon P. Sankaran K. Sheridan D.P. 2004 Mcl-1 and Bcl-2/Bax ratio are associated with treatment response but not with Rai stage in B-cell chronic lymphocytic leukemia American Journal of Hematology 75 22 33
103. Schroder-van der Elst J.P. van der Heide D. Rokos H. Morreale de Escobar G. Kohrle J. 1998 Synthetic flavonoids cross the placenta in the rat and are found in fetal brain American Journal of Physiology 274 E253 256
104. Shimizu H. Culbert S.J. Cork A. Iacuone J.J. 1989 A lineage switch in acute monocytic leukemia. A case report American Journal of Pediatric Hematology and Oncology 11 162 166
105. Shu X.O. Ross J.A. Pendergrass T.W. Reaman G.H. Lampkin B. Robison L.L. 1996 Parental alcohol consumption, cigarette smoking, and risk of infant leukemia: a Childrens Cancer Group study Journal of the National Cancer Institute 88 24 31
106. Siegel D. McGuinness S.M. Winski S.L. Ross D. 1999 Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1 Pharmacogenetics 9 113 121
107. Silverman L.B. McLean T.W. Gelber R.D. Donnelly M.J. Gilliland D.G. Tarbell N.J. Sallan S.E. 1997 Intensified therapy for infants with acute lymphoblastic leukemia: results from the Dana-Farber Cancer Institute Consortium Cancer 80 2285 2295
108. Sirma S. Agaoglu L. Yildiz I. Cayli D. Horgusluoglu E. Anak S. Yuksel L. Unuvar A. Celkan T. Apak H. Karakas Z. Devecioglu O. Ozbek U. 2004 NAD(P)H:quinone oxidoreductase 1 null genotype is not associated with pediatric de novo acute leukemia Pediatr Blood Cancer 43 568 570
109. Smith B.D. Levis M. Beran M. Giles F. Kantarjian H. Berg K. Murphy K.M. Dauses T. Allebach J. Small D. 2004 Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia Blood 103 3669 3676
110. Song G. Liao X. Zhou L. Wu L. Feng Y. Han Z.C. 2004 HI44a, an anti-CD44 monoclonal antibody, induces differentiation and apoptosis of human acute myeloid leukemia cells Leukemia Research 28 1089 1096
111. Spector L.G. Xie Y. Robison L.L. Heerema N.A. Hilden J.M. Lange B. Felix C.A. Davies S.M. Slavin J. Potter J.D. Blair C.K. Reaman G.H. Ross J.A. 2005 Maternal diet and infant leukemia: the DNA topoisomerase II inhibitor hypothesis: a report from the children's oncology group Cancer Epidemiology, Biomarkers and Prevention 14 651 655
112. Stam R.W. den Boer M.L. Meijerink J.P. Ebus M.E. Peters G.J. Noordhuis P. Janka-Schaub G.E. Armstrong S.A. Korsmeyer S.J. Pieters R. 2003 Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia Blood 101 1270 1276
113. Stam R.W. van den Heuvel-Eibrink M.M. den Boer M.L. Ebus M.E. Janka-Schaub G.E. Allen J.D. Pieters R. 2004 Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein Leukemia 18 78 83
114. Stam R.W. den Boer M.L. Schneider P. Nollau P. Horstmann M. Beverloo H.B. van der Voort E. Valsecchi M.G. de Lorenzo P. Sallan S.E. Armstrong S.A. Pieters R. 2005 Targeting FLT3 in primary MLL gene rearranged infant acute lymphoblastic leukemia Blood 106 2484 2490
115. Stam R.W. Hubeek I. den Boer M.L. Buijs-Gladdines J.G. Creutzig U. Kaspers G.J. Pieters R. 2005 MLL gene rearrangements have no direct impact on Ara-C sensitivity in infant acute lymphoblastic leukaemia and childhood M4/M5 acute myeloid leukaemia Leukemia Epub ahead of print
116. Stirewalt D.L. Radich J.P. 2003 The role of FLT3 in haematopoietic malignancies Nature Reviews Cancer 3 650 665
117. Stone R.M. DeAngelo D.J. Klimek V. Galinsky I. Estey E. Nimer S.D. Grandin W. Lebwohl D. Wang Y. Cohen P. Fox E.A. Neuberg D. Clark J. Gilliland D.G. Griffin J.D. 2005 Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412 Blood 105 54 60
118. Strick R. Strissel P.L. Borgers S. Smith S.L. Rowley J.D. 2000 Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia Proceedings of the National Academy of Sciences of the United States of America 97 4790 4795
119. Super H.J. McCabe N.R. Thirman M.J. Larson R.A. Le Beau M.M. Pedersen-Bjergaard J. Philip P. Diaz M.O. Rowley J.D. 1993 Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II Blood 82 3705 3711
120. Taki T. Ida K. Bessho F. Hanada R. Kikuchi A. Yamamoto K. Sako M. Tsuchida M. Seto M. Ueda R. Hayashi Y. 1996 Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia Leukemia 10 1303 1307
121. Thomas M. Gessner A. Vornlocher H.P. Hadwiger P. Greil J. Heidenreich O. 2005 Targeting MLL-AF4 with short interfering RNAs inhibits clonogenicity and engraftment of t(4;11)-positive human leukemic cells Blood 106 3559 3566
122. Tissing W.J. Meijerink J.P. den Boer M.L. Pieters R. 2003 Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia Leukemia 17 17 25
123. Tissing W.J. Meijerink J.P. den Boer M.L. Brinkhof B. Van Rossum E.F.C. Van Wering E.R. Koper J.W. Sonneveld P. Pieters R. 2005 Genetic variations in the glucocorticoid receptor gene are not related to glucocorticoid resistance in childhood acute lymphoblastic leukemia Clinical Cancer Research 11 6050 6056
124. Tkachuk D.C. Kohler S. Cleary M.L. 1992 Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias Cell 71 691 700
125. Traver R.D. Siegel D. Beall H.D. Phillips R.M. Gibson N.W. Franklin W.A. Ross D. 1997 Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase) British Journal of Cancer 75 69 75
126. Tsutsumi S. Taketani T. Nishimura K. Ge X. Taki T. Sugita K. Ishii E. Hanada R. Ohki M. Aburatani H. Hayashi Y. 2003 Two distinct gene expression signatures in pediatric acute lymphoblastic leukemia with MLL rearrangements Cancer Research 63 4882 4887
127. Wasserman R. Galili N. Ito Y. Reichard B.A. Shane S. Rovera G. 1992 Predominance of fetal type DJH joining in young children with B precursor lymphoblastic leukemia as evidence for an in utero transforming event Journal of Experimental Medicine 176 1577 1581
128. Weisberg E. Boulton C. Kelly L.M. Manley P. Fabbro D. Meyer T. Gilliland D.G. Griffin J.D. 2002 Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412 Cancer Cell 1 433 443
129. White J.C. Rathmell J.P. Capizzi R.L. 1987 Membrane transport influences the rate of accumulation of cytosine arabinoside in human leukemia cells Journal of Clinical Investigation 79 380 387
130. Wiemels J.L. Pagnamenta A. Taylor G.M. Eden O.B. Alexander F.E. Greaves M.F. 1999 A lack of a functional NAD(P)H:quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. United Kingdom Childhood Cancer Study Investigators Cancer Research 59 4095 4099
131. Wiley J.S. Jones S.P. Sawyer W.H. Paterson A.R. 1982 Cytosine arabinoside influx and nucleoside transport sites in acute leukemia Journal of Clinical Investigation 69 479 489
132. Wright A.M. Paterson A.R. Sowa B. Akabutu J.J. Grundy P.E. Gati W.P. 2002 Cytotoxicity of 2-chlorodeoxyadenosine and arabinosylcytosine in leukaemic lymphoblasts from paediatric patients: significance of cellular nucleoside transporter content British Journal of Haematology 116 528 537
133. Yasui H. Hideshima T. Hamasaki M. Roccaro A.M. Shiraishi N. Kumar S. Tassone P. Ishitsuka K. Raje N. Tai Y.T. Podar K. Chauhan D. Leoni L.M. Kanekal S. Elliott G. Munshi N.C. Anderson K.C. 2005 SDX-101, the R-enantiomer of etodolac, induces cytotoxicity, overcomes drug resistance, and enhances the activity of dexamethasone in multiple myeloma Blood 106 706 712
134. Yeazel M.W. Buckley J.D. Woods W.G. Ruccione K. Robison L.L. 1995 History of maternal fetal loss and increased risk of childhood acute leukemia at an early age. A report from the Childrens Cancer Group Cancer 75 1718 1727
135. Yee K.W. O'Farrell A.M. Smolich B.D. Cherrington J.M. McMahon G. Wait C.L. McGreevey L.S. Griffith D.J. Heinrich M.C. 2002 SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase Blood 100 2941 2949
136. Yee K.W. Schittenhelm M. O'Farrell A.M. Town A.R. McGreevey L. Bainbridge T. Cherrington J.M. Heinrich M.C. 2004 Synergistic effect of SU11248 with cytarabine or daunorubicin on FLT3 ITD-positive leukemic cells Blood 104 4202 4209
137. Yeoh E.J. Ross M.E. Shurtleff S.A. Williams W.K. Patel D. Mahfouz R. Behm F.G. Raimondi S.C. Relling M.V. Patel A. Cheng C. Campana D. Wilkins D. Zhou X. Li J. Liu H. Pui C.H. Evans W.E. Naeve C. Wong L. Downing J.R. 2002 Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling Cancer Cell 1 133 143
138. Zwaan C.M. Kaspers G.J. Pieters R. Ramakers-Van Woerden N.L. den Boer M.L. Wunsche R. Rottier M.M. Hahlen K. van Wering E.R. Janka-Schaub G.E. Creutzig U. Veerman A.J. 2000 Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia Blood 96 2879 2886